From the desk of Louis Sykes @haumicharts and Steve Strazza @Sstrazza
Alt Season is still very much alive and well.
In February, we did a deep dive into the wide world of crypto assets outside of Bitcoin. This turned out to be quite timely as many of these "alt-coins" have booked significant gains in the time since.
It's no longer just Bitcoin, Ethereum, Litecoin, and some others. There are thousands of cryptocurrencies out there now!
As this new asset class continues to grow and blossom, we continue to pay close attention to the leadership within the Crypto complex.
The latest Young Aristocrats report dropped on Friday last week. If you love dividends combined with momentum (who wouldn't?), then this report is always a must read.
Banks of all sizes have been a bright spot for us lately as we're currently enjoying gains in Morgan Stanley $MS and the Regional Banks ETF $KRE.
Well, this week's YA report highlighted a couple more banks with attractive setups and one in particular looks like a great setup to play with straight long call options.
Check out this week's Momentum Report, our weekly summation of all the major indexes at a Macro, International, Sector, and Industry Group level.
By analyzing the short-term data in these reports, we get a more tactical view of the current state of markets. We can then put these near-term developments into the context of the big picture and glean insights into the structural trends at play.
Let's jump right into it with some of the major takeaways from this week's report:
* ASC Plus Members can access the Momentum Report by clicking the link at the bottom of this post.
Our Top 10 report was just published. In this weekly note, we highlight 10 of the most important charts or themes we're currently seeing in asset classes around the world.
Smalls Signal An End To The Growth/Value Countertrend
One of the main themes we’ve seen unfold as the market has rallied off its recovery lows from last year is the rotation into value stocks and more cyclical areas of equity markets. We’re seeing it around the world too, and it’s also responsible for driving many other relative trends like that between small and large-caps and US vs ex-US equities.
So commodities seem like they're in the mood to rally! We've seen Base Metals have their fair share of moments in the spotlight, but what about the truly shiny commodities? Where are Gold and Silver off to, next? Or are they consolidating and quietly hatching a plan to break out soon?
Here's an update on what the (presently) less popular metals are doing.
We've already had some great trades come out of this Small-Cap focused column since we launched it late last year and started rotating it with our flagship bottoms-up scan, "Under The Hood."
Ultimately, to make the cut for our Minor Leagues list, you must have a market cap between $1 and $2B. There are also price and liquidity filters.
Then, we simply sort by proximity to new highs in order to focus on the best players only.
This week we're looking at two long setups in the Pharma sector. With Nifty Pharma breaking out above its resistance of 13,500, a couple of stocks that we've been tracking for quite some time now have also followed through with a breakout.
Let's take a look at these names and track their levels going forward.
We retired our "Five Bull Market Barometers" in mid-July to make room for a new weekly post that's focused on the three most important charts for the week ahead.
This is that post, so let's jump into this week's edition.
Every month we get a fresh batch of Monthly Candlesticks. It only happens 12 times a year.
I promise you guys from the bottom of my heart that there is no other part of my entire process that provides as much value and information as my monthly chart review. Premium Members can access the Chartbook here.
In the meantime, my friend Josh Brown and I have been doing these short monthly videos since last summer.
On this latest episode we talk about how the market is behaving like it normally does in Year 2 of Bull Market cycles. Choppy, messy, and with a much different profile than the prior year. And, not only is that normal, but anything else would be historically abnormal.
Defensive areas like Consumer Staples, Gold, Bonds and Japanese Yen have been shining. We didn't see that in Year 1. It was the exact opposite.
We like shorting the Nasdaq here and being very picky when looking for Value stocks to buy.
The story of Value stocks continuing to be the leaders is something we absolutely cannot ignore.
But have you noticed? Many investors are ignoring it, particularly in the United States. "I'm a Growth Investor", is what they tell me lol. What even is that?
You can really see this rotation taking place in the ratio between the Nasdaq100 and the NYSE Composite: